SVS: W.L. Gore & Associates Block Grant Will Support Vascular Quality

Nov 13, 2019 Re-posted from the November 2019 issue of Vascular Specialist

W.L. Gore & Associates, Inc. will support a new Society for Vascular Surgery initiative to advance patient safety programs and the quality of vascular care.

Through a general block grant, Gore will help fund SVS quality initiatives designed to improve vascular patient surgical outcomes. These related projects will address key practice factors influencing quality care, including new care delivery and payment models, patient education, costs, surgeon wellness, and the value of vascular surgery services.

First-year funding support will focus on several initiatives including:• Analysis of an advanced payment model that may improve care for patients with PAD• A summit and a call to action for SVS leaders focused on appropriateness of care• Data analysis of vascular surgeon well-being• Data collection and analysis to address valuation of vascular surgery services

Gore is committed to two additional years of funding pending progress evaluation of years one and two.

“At the highest strategic level, SVS and Gore share an important mission goal to improve the quality of lives of vascular patients,” noted SVS Executive Director Kenneth M. Slaw, PhD. “This is a new and innovative model that transcends the traditional society/industry relationship and provides an opportunity for SVS and Gore to collaborate more deeply on key quality program initiatives that matter at a mission level.”

“Gore is committed to improving the quality of health care and outcomes for all vascular patients,” concurred Eric Zacharias, vascular business leader of W.L. Gore & Associates. “Innovative collaborations such as this with the SVS reflect our shared, value-based goals.”

Tags
Vascular Specialist

Related Articles

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.

New SVS vice president, revised bylaws set to be unveiled at June 16 Annual Business Meeting

Members, be sure to register for the June 16 Virtual Annual Business Meeting, the first of two business meetings for 2021. Registration is required to assure A quorum. Register at vascular.org/ABM1Register. The second meeting will be held Saturday, Aug. 21, during the Vascular Annual Meeting (VAM). The Wednesday, June 16, meeting will be from 6 to 7 p.m. Central Daylight Time. Members will hear reports from President Ronald L. Dalman, MD, Secretary Amy Reed, MD, and Treasurer Keith Calligaro, MD. Nominating Committee Chair R. Clement Darling III, MD, will present his report, announce the results of the election for SVS vice president and on bylaws revisions, and introduce the 2021–22 Officers.